Mon Mar 20, 2023 3:14 pm
2023-Dai et al-Front Oncol
"Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden"
Mengyao Dai, Jianpeng Sheng, Qi Zhang, Jianxin Wang, Qihan Fu, Tingbo Liang
Front Oncol. 2023, 13, 1118633
https://doi.org/10.3389/fonc.2023.1118633
- "Data availability statement The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation."
Mengyao Dai, Jianpeng Sheng, Qi Zhang, Jianxin Wang, Qihan Fu, Tingbo Liang
Front Oncol. 2023, 13, 1118633
https://doi.org/10.3389/fonc.2023.1118633
- "Data availability statement The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation."